ZENVIA INC. - CLASS A COMMON STOCK
2.4600
07-February-25 16:00:05
15 minutes delayed
Stocks
-0.0700
-2.77%
Today's range
2.3750 - 2.5600
ISIN
N/A
Source
NASDAQ
-
LY (OTCMKTS:YAHOY) Issues Earnings Results | MarketBeat
07 Feb 2025 14:26:09 By Buzz FX
-
Robert Andrew Mionis Sells 20,429 Shares of Celestica Inc. (TSE:CLS) Stock
07 Feb 2025 14:26:09 By Buzz FX
-
The Goldman Sachs Group Boosts Spotify Technology (NYSE:SPOT) Price Target to $695.00
07 Feb 2025 14:26:09 By Buzz FX
-
Skyworks Solutions (NASDAQ:SWKS) Price Target Lowered to $70.00 at The Goldman Sachs Group
07 Feb 2025 14:26:09 By Buzz FX
-
Alibaba Group Target of Unusually High Options Trading (NYSE:BABA)
07 Feb 2025 14:26:09 By Buzz FX
-
Thomson Reuters (TSE:TRI) Reaches New 52-Week High After Strong Earnings
07 Feb 2025 14:26:09 By Buzz FX
-
Nebius Group Target of Unusually Large Options Trading (NASDAQ:NBIS)
07 Feb 2025 14:26:09 By Buzz FX
-
Stock Traders Buy High Volume of International Business Machines Call Options (NYSE:IBM)
07 Feb 2025 14:26:09 By Buzz FX
-
Teijin (OTCMKTS:TINLY) Issues Quarterly Earnings Results
07 Feb 2025 14:26:09 By Buzz FX
-
Telenor ASA (OTCMKTS:TELNY) Releases Earnings Results, Misses Estimates By $0.01 EPS
07 Feb 2025 14:26:09 By Buzz FX
-
07 Feb 2025 14:26:09 By Buzz FX
-
Sampo Oyj (OTCMKTS:SAXPY) Issues Earnings Results
07 Feb 2025 14:26:09 By Buzz FX
-
Suzuki Motor (OTCMKTS:SZKMY) Posts Quarterly Earnings Results, Beats Estimates By $0.25 EPS
07 Feb 2025 14:26:09 By Buzz FX
-
Trump says US and Japan will work to cut trade deficit as he greets Ishiba
07 Feb 2025 14:12:20 By Buzz FX
-
January Jobs Report Keeps Rates on Pause: What the Experts Are Saying
07 Feb 2025 14:11:22 By Buzz FX
-
Royal Bank of Canada Cuts Veralto (NYSE:VLTO) Price Target to $110.00
07 Feb 2025 14:01:09 By Buzz FX
-
Cytokinetics' (CYTK) "Buy" Rating Reiterated at Needham & Company LLC
07 Feb 2025 14:01:09 By Buzz FX
-
The Goldman Sachs Group Has Lowered Expectations for Ternium (NYSE:TX) Stock Price
07 Feb 2025 14:01:09 By Buzz FX
-
Impinj (NASDAQ:PI) Price Target Lowered to $132.00 at The Goldman Sachs Group
07 Feb 2025 14:01:09 By Buzz FX
-
Immuneering (NASDAQ:IMRX) Earns "Buy" Rating from Needham & Company LLC
07 Feb 2025 14:01:09 By Buzz FX